Trastuzumab - ~21mg/ml(in buffer,pH6.0),95%, high purity , CAS No.180288-69-1

1 Citations
  • ≥95%
  • ~21mg/ml(in buffer,pH6.0)
Features and benefits
    Item Number
    T305227
    Grouped product items
    SKUSizeAvailabilityPrice Qty
    T305227-1mg
    1mg
    Available within 4-8 weeks(?)
    Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!
    $189.90
    T305227-5mg
    5mg
    Available within 4-8 weeks(?)
    Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!
    $652.90
    T305227-10mg
    10mg
    Available within 4-8 weeks(?)
    Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!
    $1,175.90
    T305227-25mg
    25mg
    Available within 4-8 weeks(?)
    Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!
    $2,474.90

    Basic Description

    Product NameTrastuzumab - ~21mg/ml(in buffer,pH6.0),95%, high purity , CAS No.180288-69-1
    Synonyms8-Aminoguanosine|3868-32-4|Guanosine, 8-amino-|180288-69-1|SHO2CA1BRO|CHEMBL2021376|2,8-DIAMINO-9-[(2R,3R,4S,5R)-3,4-DIHYDROXY-5-(HYDROXYMETHYL)OXOLAN-2-YL]-1H-PURIN-6-ONE|NSC 90390|NSC-90390|2,8-diamino-9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxo
    Specifications & Purity≥95%, ~21mg/ml(in buffer,pH6.0)

    Product Properties

    Concentration~21mg/ml(in buffer,pH6.0)
    Storage TempProtected from light,Store at -20°C
    Shipped InIce chest + Ice pads
    CAS180288-69-1

    Associated Targets(Human)

    ERBB2 Tclin Receptor tyrosine-protein kinase erbB-2 (0 Activities)
    Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
    ERBB2 Tclin Receptor protein-tyrosine kinase erbB-2 (7851 Activities)
    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
    ERBB2 Tclin Epidermal growth factor receptor and ErbB2 (HER1 and HER2) (186 Activities)
    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
    ERBB2 Tclin Epidermal growth factor receptor (487 Activities)
    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
    ERBB2 Tclin FASN/HER2 (2 Activities)
    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
    ERBB2 Tclin ErbB-2/ErbB-3 heterodimer (2 Activities)
    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    Certificates

    Certificate of Analysis(COA)

    Enter Lot Number to search for COA:

    To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section

    9 results found

    Lot NumberCertificate TypeDateItem
    H2117224Certificate of AnalysisJun 20, 2024 T305227
    H2117374Certificate of AnalysisJun 20, 2024 T305227
    G23201173Certificate of AnalysisJun 30, 2023 T305227
    G23201180Certificate of AnalysisJun 30, 2023 T305227
    G23201191Certificate of AnalysisJun 30, 2023 T305227
    H2213231Certificate of AnalysisJul 19, 2022 T305227
    H2213232Certificate of AnalysisJul 19, 2022 T305227
    H2213233Certificate of AnalysisJul 19, 2022 T305227
    F2223136Certificate of AnalysisAug 06, 2021 T305227

    Safety and Hazards(GHS)

    Pictogram(s) GHS08
    Signal Danger
    Hazard Statements

    H360:May damage fertility or the unborn child

    Precautionary Statements

    P280:Wear protective gloves/protective clothing/eye protection/face protection.

    P405:Store locked up.

    P501:Dispose of contents/container to ...

    P203:Obtain, read and follow all safety instructions before use.

    P318:if exposed or concerned, get medical advice.

    Related Documents

    Citations of This Product

    1. Dongmei Li, Chaofan Weng, Chaoyi Chen, Kan Li, Qiang Lin, Yi Ruan, Yi Ruan, Jingjing Zhang, Shuqian Wang, Jia Yao, Jia Yao.  (2022)  Optical biosensor based on weak value amplification for the high sensitivity detection of Pertuzumab in combination with Trastuzumab binding to the extracellular domain of HER2.  OPTICS EXPRESS,  30  (20): (36839-36848).  [PMID:36258605]

    References

    1. Dongmei Li, Chaofan Weng, Chaoyi Chen, Kan Li, Qiang Lin, Yi Ruan, Yi Ruan, Jingjing Zhang, Shuqian Wang, Jia Yao, Jia Yao.  (2022)  Optical biosensor based on weak value amplification for the high sensitivity detection of Pertuzumab in combination with Trastuzumab binding to the extracellular domain of HER2.  OPTICS EXPRESS,  30  (20): (36839-36848).  [PMID:36258605]

    Solution Calculators